SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is trending as investors react to a significant sell-off following disappointing revenue guidance and projections of a steep decline in the Chinese market. Community sentiment is deeply divided, with some investors viewing the price drop as a rare entry point for a long-term 'dividend aristocrat' play, while others warn of a 'value trap' due to stalled growth and ongoing concerns regarding management's turnaround strategy.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is experiencing high volatility as investors react to mixed quarterly earnings and the companys ongoing struggles with trade tariffs and a challenging housing market. While the community remains deeply divided, with many debating whether the stock is a long-term value opportunity or a failing luxury retailer, the stock continues to see significant short interest and intense speculation regarding future legal developments surrounding trade policy.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened community discussion and bullish sentiment following a significant stake acquisition by Bill Ackman, driving speculation about a potential turnaround and a massive short squeeze. Investors are closely monitoring key technical resistance levels while debating the impact of upcoming debt obligations and the company's long-term strategy.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending due to the announcement of a massive multi-year AI infrastructure contract, which has sparked intense community debate regarding its low-float potential for a significant squeeze. Investors are actively discussing the stock's future, weighing the deal's long-term value against frustrations over current volume, price action, and perceived manipulation.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune is trending as investors debate its potential for volatile, high-percentage swings characteristic of low-float Chinese IPOs, drawing comparisons to previous market runners. While some traders are aggressively positioning for a rapid squeeze fueled by lock-up dynamics, many participants are cautioning others about the significant risks associated with its history of extreme volatility and pump-and-dump patterns.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing heightened retail interest as traders monitor its history of volatile, low-float runs and speculate on the potential for a short squeeze. Community discussion is heavily focused on the stock's lack of available shares to borrow, extreme cost-to-borrow fees, and comparisons to previous multi-bagger rallies, with many debating whether this represents a genuine reversal or a potential liquidity trap.

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF is trending as investors seek exposure to the anticipated SpaceX IPO and broader space sector growth. While some community members are optimistic about its focus on space technology and satellite infrastructure, others are actively debating its low assets under management and comparing its potential performance and strategy to other existing space-linked investment vehicles.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is experiencing intense market speculation driven by recurring buyout rumors involving major technology and aerospace players like SpaceX and Amazon. Investors are actively debating the potential valuation of the company's critical spectrum assets and satellite infrastructure, fueled by anticipation of upcoming earnings and recent industry partnerships.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating buzz as investors speculate on a potential breakout driven by its low circulating supply and market cap, with community members actively discussing a possible resurgence in the NFT sector. While some are optimistic about the project's long-term utility and future exchange listings, others remain skeptical, highlighting volatility and the need for sustained trading volume.

ElizaAgentic

ElizaAgentic is experiencing a surge in momentum and heightened social media activity as traders emphasize the asset's clean technical structure and bullish price continuation. The community is actively drawing parallels to broader market trends across major chains, fueling widespread speculation on its potential trajectory.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cipla, Pfizer ink partnership for exclusive marketing of four brands in India

Pfizer India and Cipla Limited have announced a strategic partnership where Cipla will exclusively market and distribute four of Pfizer's key brands in India. This collaboration aims to leverage Cipla's extensive distribution network to enhance patient access to essential medicines like Corex Dx, Dolonex, Neksium, and Dalacin C across the country.

Vietnam's Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025

HO CHI MINH CITY, Vietnam , Oct. 10, 2025 /PRNewswire/ -- Vietnam's most visionary leaders and trailblazing enterprises took center stage at the Asia Pacific Enterprise Awards (APEA) 2025 Vietnam, held on 9 October 2025 at the GEM Center, Ho Chi Minh City . Organized by leading regional NGO Enterprise Asia, the prestigious awards program honored businesses and business leaders who are reshaping industries, embracing innovation, and driving sustainable growth. Vietnam’s Visionary Leaders Redefine Success at the Asia Pacific Enterprise Awards 2025 With the theme 'Showcasing Future-Ready Enterprises', this year's APEA celebrated organizations and leaders who are future-proofing their businesses amidst sweeping technological disruption and shifting economic landscapes. A highly selective judging process evaluated 342 nominees across four award categories: Master Entrepreneur, Inspirational Brand, Fast Enterprise, and Corporate Excellence. Each recipient stood out for their resilience, innovation, and commitment to creating lasting impact.

Indian equity markets snapped their eight-day losing streak, with the Nifty index reclaiming 24,800, driven by a 700-point rally in Nifty Bank. This came after the Reserve Bank of India held steady on repo rates and revised inflation forecasts lower. The central bank also announced a slew of reforms for the banking space, including increased loan limits.On Wednesday, the Sensex closed 715 points higher at 80,983, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 225 points at 24,836. Broader markets mirrored the optimism, with the Nifty Midcap index rising 0.8% and the Smallcap index gaining 1.1%.However, the retail investor sentiment surrounding the Nifty 50 remained ‘bearish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:813/102;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_155746_png_5955436f5e.webp" alt="Screenshot 2025-10-01 155746.png" width="813" height="102"><figcaption>Nifty sentiment and message volume on Oct 1 as of 3:50 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesSectorally, barring PSU banks, all indices ended in the green. Media (+4%), pharmaceuticals (+1.2%), and real estate (+1%) saw strong buying. A notable mover in the media space was Sun TV, which closed with 12% gains.Kotak Mahindra Bank, Axis Bank, ICICI Bank, and HDFC Bank were among the top Nifty gainers, driven by the RBI’s reforms push.&nbsp;<a href="https://stocktwits.com/symbol/TATAMOTORS.NSE">Tata Motors</a> ended over 5% higher after its <a href="https://stocktwits.com/news-articles/markets/equity/tata-motors-demerger-takes-effect-retail-investors-to-benefit-says-analyst/chCor1mR39A">demerger</a> came into effect; the record date has been set at October 14.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India</a> rose 3% after US President Donald Trump announced a deal with the American parent company to provide key prescription medications at steeply discounted prices through a new government-run online platform. The rest of the pharmaceutical space also saw a relief rally, with Sun Pharma and Lupin gaining 3%.&nbsp;Shriram Finance gained 5% after the company shot down reports that Japan’s Mitsubishi UFJ Financial Group (MUFG) was in talks to buy a 20% stake worth ₹23,200 crore.Stock Calls<a href="https://stocktwits.com/equitycharcha">Ashok Kumar Aggarwal of Equity Charcha</a> is bullish on TVS Supply Chain Solutions. It recently inaugurated a new facility in Iowa (USA) to support local manufacturing. On its technical charts, he noted that its Relative Strength Index (RSI) was ranging between 37 and 45 on its daily, weekly, and monthly time frame charts.&nbsp;He shared a short-to-medium term trade call on TVS Supply with an accumulation zone between ₹124-₹126 with a stop loss at ₹118 on a closing basis. The short-term target is set at ₹142, and a medium-term target price is ₹161.<stembedurl>https://stocktwits.com/equitycharcha/message/630578691</stembedurl><a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> shared a swing trade call on&nbsp;<a href="https://stocktwits.com/symbol/HINDZINC.NSE">Hindustan Zinc</a>. He noted that the stock was consolidating near the gap resistance at ₹483.05, with rising volumes indicating strong upside interest. Chandel recommended a buy on a close above ₹483.05, with a stop loss at ₹463 and a target price of ₹535.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/630585738</stembedurl>Markets: What Next?<a href="https://stocktwits.com/WealthFino">Krishna Pathak&nbsp;</a>highlighted Nifty support near the 24,540–24,600 zone, with immediate resistance around the 24,800–24,900 levels. He added that the index was trading above the 9-day Exponential Moving Average (EMA), which indicates a short-term bullish momentum. If it breaks out above 24,800, it could open the path towards 24,900–25,100. But sustained weakness below 24,600 can extend declines towards 24,540.<stembedurl>https://stocktwits.com/WealthFino/message/630580092</stembedurl>Globally, European markets traded higher, while US stock futures indicate a weak start on Wall Street after a deadlock over healthcare and government spending led to the US government shutdown for a first time in nearly seven years.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Banking Rally Lifts Indian Markets: RBI Policy Boosts Nifty To 24,800, Sensex Ends Near 81,000

Benchmarks staged a strong comeback on RBI’s supportive policy measures, though retail sentiment on Nifty 50 remained ‘bearish’ on Stocktwits.

Equity

Shares of Pfizer, the Indian arm of U.S.-based Pfizer Inc., rose more than 2% on Wednesday after President Donald Trump announced a deal with the drugmaker to provide key prescription medications at steeply discounted prices through a new government-run online platform, ‘TrumpRX.’Deal AnnouncementSpeaking at the White House, Trump said Pfizer agreed to supply several of its most widely used drugs at “heavily discounted prices of anywhere between 50% and even 100%,” allowing patients to pay cash directly on the new TrumpRX website.&nbsp;He added that all new Pfizer drugs introduced in the U.S. will be sold at “most favored patient costs,” ensuring prices are comparable to the lowest charged internationally.Pfizer CEO Albert Bourla said the company’s deal with the Trump administration satisfies all of the President’s requirements.&nbsp;He added that Pfizer has secured a three-year grace period from proposed tariffs on pharmaceutical imports, while also cutting prices on certain drugs. “The President is absolutely right—tariffs are the most powerful tool to motivate behavior, and they clearly motivated ours,” Bourla said.Trump also warned that companies refusing to lower prices could face additional tariffs of 5% to 8%, as his administration continues to pressure drugmakers to expand U.S.-based production before Oct. 1, 2025.Analyst ViewSEBI-registered analyst Sunil Kotak said that Pfizer’s daily chart shows a sideways trend, with the 50-day simple moving average (SMA) around ₹5,200 and a strong supply zone between ₹5,200–₹5,300.&nbsp;<stembedurl>https://stocktwits.com/Technofunda24/message/630578299</stembedurl>He noted that the stock would need to close above ₹5,300 for a fresh up-move, while the relative strength index (RSI) stands at 52, indicating consolidation for now.What Is The Retail Mood?On Stocktwits, retail sentiment for Pfizer was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer’s stock</a> has declined 2.8% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, Pfizer’s logo is on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Pfizer India Rises On Trump’s Drug Discount Deal — SEBI Analyst Eyes Breakout Above ₹5,300

Pfizer shares rose after the U.S. drugmaker struck a deal with the Trump administration to sell key medicines at steep discounts through a new federal website.

Indian equity markets have opened on a positive note as investors await the rate decision from India’s central bank. The street is expecting the Reserve Bank of India (RBI) to maintain a status quo with a dovish tone, but some expect a 25 bps rate cut.At 09:40 a.m. IST, the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> traded 59 points higher at 24,670, while the Sensex was up 182 points at 80,450. Broader markets were mixed, with the Nifty Midcap index rising 0.2% and Smallcap index trading flat.The retail sentiment on Stocktwits for the Nifty remained ‘bearish’ at market open.&nbsp;<figure class="image"><img style="aspect-ratio:802/94;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_01_094251_png_63cb54d831.webp" alt="Screenshot 2025-10-01 094251.png" width="802" height="94"><figcaption>Nifty sentiment and message volume on Oct 1 as of 9:40 am IST. | source: Stocktwits</figcaption></figure>Stock WatchSectorally, barring IT and PSU banks, rest of the sectors traded in the green, led by media, pharmaceuticals, real estate and autos.&nbsp;Shriram Finance rose over 2% as news reports suggest that Japan's MUFG is looking to buy a 20% stake in the company.&nbsp;Tata Motors rose 1% as its long-awaited demerger into passenger and commercial vehicle units takes effect today. <a href="https://stocktwits.com/symbol/TATAINVEST.NSE">Tata Investment</a> continues its bull run, with 4% gains in opening trade. Tata Sons, the holding company of Tata Group, holds a 0.10% stake in Tata Investment and has missed a regulatory deadline to become publicly listed as per RBI norms for NBFCs.&nbsp;<a href="https://stocktwits.com/symbol/PFIZER.NSE">Pfizer India shares</a> surged 5% after its US parent company received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Lupin gained 3% following a USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).<a href="https://stocktwits.com/symbol/RATEGAIN.NSE">RateGain shares</a> fell 3% as the company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software rose 2% on securing multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million. RITES too gained over 2% following a pact with Etihad Rail.&nbsp;Atlantaa shares surged 20% after the company entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Stock CallsAnalyst&nbsp;<a href="https://stocktwits.com/Wisebull_co_in">Vinayak Gautam</a> shared three stock recommendations for Wednesday with a 1-week timeframe:<a href="https://stocktwits.com/symbol/JSWSTEEL.NSE">JSW Steel</a>: Buy at ₹1,142, with a target price of ₹1,164, and stop loss at ₹1,130<a href="https://stocktwits.com/symbol/RITES.NSE">RITES</a>: Buy at ₹246.04, with a target price of ₹254, and stop loss at ₹243<a href="https://stocktwits.com/symbol/AGIIL.NSE">Agi Infra</a>: Buy at ₹1,260, with a target price of ₹1280, and stop loss at ₹1,250<stembedurl>https://stocktwits.com/Wisebull_co_in/message/630573311</stembedurl>Markets: The Road AheadFrom a technical standpoint, SEBI-registered analysts on Stocktwits shared the trade setup.&nbsp;Analyst&nbsp;<a href="https://stocktwits.com/kyalashish">Ashish Kyal</a> said the Nifty index is managing to show reduced momentum on the downside, but has yet to see a close above the prior high. For Wednesday, a break below 24,580 can take prices to 24,520-24,480 levels. A close above<a href="https://stocktwits.com/topic/Gann">&nbsp;</a>Gann levels of 24,728 on a 15-minute timeframe is required to resume a positive trend to 24,780-24,820. A move is expected 10 minutes after the RBI policy decision.<stembedurl>https://stocktwits.com/kyalashish/message/630572014</stembedurl><a href="https://stocktwits.com/prabhatmittal1">Prabhat Mittal</a> identified Nifty support at 24,450 with resistance at 24,850. For Bank Nifty, he sees support at 54,300 and resistance at 54,900.<stembedurl>https://stocktwits.com/prabhatmittal1/message/630571237</stembedurl>Global CuesGlobally, Asian markets traded mostly higher, while crude oil prices held steady.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Indian Markets Open Firm Ahead Of RBI Policy; Tata Investment, Pfizer, Shriram Finance Gain Ground

 Pharma, autos, and media stocks led early gains, while Tata Motors and Atlantaa were among top movers.

Indian stocks are poised for a subdued opening on Wednesday, as the GIFT Nifty — an early indicator for the Nifty 50 index — traded flat ahead of the market open. Benchmark indexes ended lower for the eighth straight session on Tuesday, with the Nifty index closing below 24,700.All eyes will also be on the Reserve Bank of India’s (RBI) rate decision due at 10 am today. Economists expect the central bank to hold steady on rates but a dovish tone could open the path for further rate cuts going forward. Rate sensitive sectors will be in focus today.&nbsp;Most major Asian markets were mostly higher in morning trade, barring Japanese Nikkei that was down nearly 1%. Chinese markets are shut for a week for National Day holidays.Stock WatchPfizer India: The US parent company has received a three-year reprieve from tariffs on pharmaceutical imports imposed by US President Donald Trump.Aurobindo, Dr Reddy’s, other Indian pharma companies: Trump's 100% tariff on pharma takes effect todayLupin - Got USFDA nod for Rivaroxaban oral suspension drug, used to treat venous thromboembolism (VTE).Auto stocks - Investors will be tracking September sales data.Shriram Finance - News reports suggest that Japan's MUFG is looking to buy 20% stake in the company.&nbsp;Nestle India - Has signed a Memorandum of Understanding (MoU) to boost investments in Odisha &amp; existing plants.Shree Cement - The company commissioned 3.65 MTPA clinkerisation unit in Rajasthan.Indian Overseas Bank - Got ₹31.8 lakh penalty notice from RBI for non-compliance of its Priority Sector Lending (PSL) targets and classification norms.OIL India &amp; GAIL - signed a pact to boost collaboration across the natural gas value chainRateGain - The company is considering acquiring Sojern and its subsidiaries through its wholly-owned subsidiary for $250 million.Newgen Software - Company has signed multiple deals across the UK, US, Ghana, and Dubai, with total contract wins exceeding $9 million.RITES - The company has signed a pact with Etihad Rail and its subsidiary to boost collaboration in the mobility sector across the UAE.&nbsp;Atlantaa - The company has entered into an agreement with IRCON International for undertaking a contract worth ₹2,485 crore.Swan Defence has signed a Memorandum of Understanding (MoU) with Samsung Heavy Industries to jointly explore commercial shipbuilding and heavy engineering projects across domestic and international markets.Mainboard Listing Today&nbsp;Epack Prefab Technologies, BMW Ventures, and Jain Resource RecyclingFor updates and corrections, email newsroom[at]stocktwits[dot]com.

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Sensex, Nifty Poised For Quiet Start; Pfizer, Lupin, Tata Motors, RateGain, Newgen, RITES On Stock Watchlist

 After eight days of losses, markets may see a cautious start as the RBI policy decision takes center stage. Stock-specific action is expected in pharma, auto, and PSU banking counters.

DPIIT partners with Pfizer to boost lab-to-market pathway for healthcare innovation

New Delhi, Sep 4 : The Department for Promotion of Industry and Internal Trade (DPIIT) has signed a Memorandum of Understanding (MoU) with US-based pharma giant Pfizer to strengthen Indias healthcare and accelerate the lab-to-market journey of healthcare innovations, the Ministry of Commerce and Industry said on Thursday. The collaboration will extend both financial and non-financial support to startups. Under the partnership, the Pfizer INDovation programme will empower DPIIT-recognised startups with grants of up to Rs 60 lakhs each, along with a tailored 18-month incubation programme delivered by Social Alpha. The programme will provide dedicated acceleration tracks covering clinical validation, regulatory approvals, and go-to-market strategies. Startups will also gain access to expert mentorship, infrastructure, and global networks, in addition to exposure at Pfizers Research and Development facilities in Chennai, enabling them to strengthen innovations with advanced industry insights, the Ministry said.

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. Its product offerings include treatment for depression, erectile dysfunction, high cholesterol, human immunodeficiency virus infection, hypertension, bacterial infections and systemic fungal infections, and other chronic therapeutic which includes pain, respiratory, vitamins or minerals, hospital anti-infectives, neurosciences, and cardiovascular. The firm's products include Prevenar 13, Ativan, Zosyn, Minipress XL, Meronem, Enbrel, Dolonex, Magnex, Trulimax, Neksium, Becosules, Gelusil, Mucaine, Folvite, Autrin, Citralka, and Corex Range. It operates through the India and Outside of India geographical segments. The company was founded on November 21, 1950 and is headquartered in Mumbai, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	45.00	--	--	N/A
Q3 '25	36.60	--	--	N/A
Q2 '25	42.60	41.30	-3.05%	MISSED
Q1 '25	34.70	41.90	20.75%	BEAT
Q4 '24	35.85	--	--	N/A

PFIZER.NSE
Pfizer Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PFIZER.NSE News

PFIZER.NSEPfizer Ltd.